EYEGW - Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs
Previous close
0.0252
0 0%
Share volume: 0
Last Updated: Wed 05 Aug 2020 06:00:00 AM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$0.03
0.00
0.00%
Summary score
62%
Profitability
75%
Dept financing
25%
Liquidity
18%
Performance
70%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EYEGW | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 0% | -7.12% | -82.7% | -28.34% |
| Return on assets | 0% | -6.37% | -6.39% | -11.32% |
| Return on sales | 0% | 0% | -592.81% | 0% |
| Return on invested capital | 0% | -93.36% | -39.78% | 65.69% |
| Profitability | 75% | 0% | 0% | 25% |
| Total debt ratio | 0% | 15.03% | 89.22% | 39.55% |
| Debt ratio change over time | 0% | -0.99% | -8.16% | -0.59% |
| Dept financing | 25% | 4% | 25% | 11% |
| Current Ratio | 0% | 12.57% | 0.77% | 8.27% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 0% | 6.67% | 0.63% | 2.73% |
| Liquididy | 0% | 50% | 40% | 26% |
| Short-term ratios | EYEGW | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 0% | -13.83% | 124.28% | -7.01% |
| Return on assets | 0% | -12.07% | -6.93% | -6.25% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 0% | -7.47% | -50.2% | -29.16% |
| Profitability | 75% | 0% | 25% | 0% |
| Total debt ratio | 0% | 13.61% | 106.64% | 15.09% |
| Debt ratio change over time | 0% | -1.02% | -10.07% | -0.85% |
| Dept financing | 25% | 3% | 25% | 4% |
| Current Ratio | 0% | 12.57% | 0.77% | 8.27% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 0% | 6.67% | 0.63% | 2.73% |
| Liquididy | 25% | 50% | 4% | 27% |